|
|
| |
Who Uses DAWN?—Federal Agencies
|
|
| |
|
- The White House Office of National Drug Control Policy
(ONDCP) uses DAWN to assess progress and pinpoint
problems in controlling drug abuse in the U.S. DAWN is
an essential component of ONDCP’s 25-Cities Initiative,
which is aimed at developing coordinated local efforts
to understand and respond to drug abuse.
- The Food and Drug Administration has relied on
DAWN for many years to assess the abuse potential of prescription
drugs—information used in decision-making on drug
scheduling and labeling. Now, the FDA uses data from New DAWN
for post-marketing surveillance and to identify adverse
reactions and other health consequences of prescription
drugs.
- The Substance Abuse and Mental Health Services Administration
(SAMHSA) uses DAWN to identify emerging drug abuse
problems, new populations affected, and needs for prevention
and treatment services. SAMHSA regulates buprenorphine,
a new treatment for opiate addiction, and uses DAWN to
monitor ED visits associated with buprenorphine.
|
 |
| |
|
Download More Information
Fact Sheets
|
|
 |
|
|
|
| |
|
|
